22NW, LP

CIK 1694297 · last filed 2026-03-25

22NW, LP is a corporate insider who has filed 15 SEC Form 4 insider transactions across 8 companies since 2019. The most recent filing shows the insider sold $15.2M of FSTR on Mar 25, 2026. Across all open-market trades the lifetime net is +$38.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $57.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$57.63M

Companies

8

Total Filings

15

Lifetime Open-Market Net

$38.88M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FSTR 10%+ Owner 1,108,413 $39.58 $43.87M -$15.21M 1 2026-03-25
LFCR 10%+ Owner 1,714,070 $4.66 $7.99M -$1.45M 1 2025-05-07
CULP 10%+ Owner 1,712,754 $3.37 $5.77M $9.45M 2 2025-03-12
Anebulo Pharmaceuticals, Inc. (ANEB) Delisted 10%+ Owner 0 $0.36 $0 $0 1 2023-12-20
STRATA Skin Sciences, Inc. (SSKN) Delisted 10%+ Owner 536,995 $0.15 $80.5K $5.12M 1 2023-08-18
DIRTT ENVIRONMENTAL SOLUTIONS LTD (DRTT) Delisted 10%+ Owner 19,234,034 $0.33 $6.43M $45.09M 4 2022-12-01
Armstrong Flooring, Inc. (AFI) Delisted 0 $0.35 $0 -$6.11M 1 2022-05-04
MERRIMACK PHARMACEUTICALS INC (MACK) Delisted 10%+ Owner 1,175,136 $15.13 $17.78M $1.99M 1 2019-04-09

Recent Filings

15 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-25 FSTR Sell (S) −535,095 -$15.21M EDGAR
2025-05-07 LFCR Sell (S) −205,455 -$1.45M EDGAR
2025-03-12 CULP Buy (P) +432,945 $2.14M EDGAR
2024-09-19 CULP Buy (P) +1,200,235 $7.31M EDGAR
2024-08-05 Sell (S) $0
2024-01-23 Mixed +148,835,275 $52.09M
2023-12-20 Anebulo Pharmaceuticals, Inc. (ANEB) Delisted Mixed +900,000 $0 EDGAR
2023-09-21 Buy (P) $0
2023-08-18 STRATA Skin Sciences, Inc. (SSKN) Delisted Buy (P) +9,265,280 $5.12M EDGAR
2022-12-01 DIRTT ENVIRONMENTAL SOLUTIONS LTD (DRTT) Delisted Buy (P) +15,625,000 $5.00M EDGAR
Showing 110 of 15
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.